Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Nature Nanotechnology|March 10, 2015
An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cellsJonathan J Powell, Emma Thomas-McKay, Vinay Thoree, et al.
Transplantation and Cellular Therapy|July 28, 2024
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMORebeca Bailén, Gloria Iacoboni, Javier Delgado, et al.
Journal of Hematology & Oncology|May 7, 2022
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disordersJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Haematologica|June 30, 2022
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphomaMi Kwon, Gloria Iacoboni, Juan Luis Reguera, et al.
Blood|March 27, 2025
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosisJuan Carlos Hernandez-Boluda, Adrian Mosquera Orgueira, Luuk Gras, et al.
Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
Blood Cancer Journal|March 15, 2018
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasmsValerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, et al.
BMC Medicine|November 22, 2024
Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysisIsabel Omaña-Guzmán, Marisol Rosas-Diaz, Yoscelina Estrella Martínez-López, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Annals of Hematology|November 18, 2018
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patientsValentín García-Gutiérrez, Dragana Milojkovic, Juan Carlos Hernandez-Boluda, et al.
Pageof 20